CompletedPhase 2/3

Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture

France19 participantsStarted 2005-10

Plain-language summary

The purpose of this study is to determine the impact of in situ fibrinolysis on the mortality at 30 days in case of subarachnoid hemorrhage.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * subarachnoid hemorrhage by aneurysm rupture * severe intraventricular hemorraghia Exclusion Criteria: * pregnant women * hemostasis disturbance

What they're measuring

assessment of mortality

Timeframe: at 30 days

Trial details

NCT IDNCT00823485

SponsorCentre Hospitalier Universitaire de Nice

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-12

View on ClinicalTrials.gov More Aneurysm, Ruptured trials